| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 5691796 | European Journal of Obstetrics & Gynecology and Reproductive Biology | 2016 | 27 Pages | 
Abstract
												AFG or lipofilling appears to be an oncological safe technique with a low morbidity in women with a history of breast cancer. In order to have a better understanding and evidence of the oncological safety a randomised controlled trial is urgently needed. We further recommend that all AFG be registered in the cancer register.
											Related Topics
												
													Health Sciences
													Medicine and Dentistry
													Obstetrics, Gynecology and Women's Health
												
											Authors
												M. De Decker, L. De Schrijver, F. Thiessen, T. Tondu, M. Van Goethem, W.A. Tjalma, 
											